- Home
- CYBN vs RPT Comparison
CYBN vs RPT Comparison
Compare CYBN & RPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- RPT
- Stock Information
- Founded
- CYBN 2019
- RPT 2014
- Country
- CYBN Canada
- RPT United States
- Employees
- CYBN N/A
- RPT N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- RPT
- Sector
- CYBN Health Care
- RPT
- Exchange
- CYBN Nasdaq
- RPT NYSE
- Market Cap
- CYBN 153.7M
- RPT 135.3M
- IPO Year
- CYBN N/A
- RPT N/A
- Fundamental
- Price
- CYBN $5.91
- RPT $2.85
- Analyst Decision
- CYBN Strong Buy
- RPT Strong Buy
- Analyst Count
- CYBN 4
- RPT 1
- Target Price
- CYBN $86.00
- RPT $4.00
- AVG Volume (30 Days)
- CYBN 156.6K
- RPT 231.0K
- Earning Date
- CYBN 02-11-2025
- RPT 01-01-0001
- Dividend Yield
- CYBN N/A
- RPT 8.44%
- EPS Growth
- CYBN N/A
- RPT N/A
- EPS
- CYBN N/A
- RPT N/A
- Revenue
- CYBN N/A
- RPT N/A
- Revenue This Year
- CYBN N/A
- RPT N/A
- Revenue Next Year
- CYBN N/A
- RPT N/A
- P/E Ratio
- CYBN N/A
- RPT N/A
- Revenue Growth
- CYBN N/A
- RPT N/A
- 52 Week Low
- CYBN $5.81
- RPT $2.65
- 52 Week High
- CYBN $17.86
- RPT $3.91
- Technical
- Relative Strength Index (RSI)
- CYBN 21.10
- RPT N/A
- Support Level
- CYBN $7.16
- RPT N/A
- Resistance Level
- CYBN $7.09
- RPT N/A
- Average True Range (ATR)
- CYBN 0.35
- RPT 0.00
- MACD
- CYBN -0.07
- RPT 0.00
- Stochastic Oscillator
- CYBN 5.03
- RPT 0.00
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
About RPT RITHM PROPERTY TRUST INC
Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.